デフォルト表紙
市場調査レポート
商品コード
1623670

次世代シーケンシングサービス市場規模、シェア、成長分析、タイプ別、技術別、ワークフロー別、最終用途別、用途別、地域別 - 産業予測、2025~2032年

Next-Generation Sequencing Services Market Size, Share, Growth Analysis, By Type, By Technology, By Workflow, By End Use, By Application, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.30円
次世代シーケンシングサービス市場規模、シェア、成長分析、タイプ別、技術別、ワークフロー別、最終用途別、用途別、地域別 - 産業予測、2025~2032年
出版日: 2024年12月29日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

次世代シーケンシングサービスの世界市場規模は、2023年に84億米ドルと評価され、予測期間(2025-2032年)のCAGRは22.4%で、2024年の102億8,000万米ドルから2032年には518億米ドルに成長する見通しです。

次世代シーケンシング(NGS)は、超並列シーケンシングとしても知られ、迅速かつ高スループットのDNAシーケンシングを可能にすることで、バイオテクノロジー、医療診断、ウイルス学などの分野に革命をもたらしています。この技術は、従来のサンガー法に比べてヒトゲノムの全塩基配列決定に要する時間を大幅に短縮し、臨床研究や応用研究を強化します。NGSは重要なDNAプレシーケンス工程を容易にし、サンプル調製と解析を合理化します。臨床検査室での応用が拡大しているNGSは、薬理ゲノミクスにおいて、より迅速な疾病診断とより効率的な創薬を可能にします。早期発見のためのバイオマーカーを同定し、個別化治療戦略を可能にすることで、NGSは精密医療へのシフトを促進し、比較的新しい市場であるにもかかわらず、分子生物学と遺伝学に変革をもたらすインパクトを実証しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析

次世代シーケンシングサービス市場規模:タイプ別

  • 市場概要
  • ヒトゲノム配列
  • 単一細胞シーケンシング
  • 微生物ゲノムに基づく配列解析
  • 遺伝子制御サービス
    • 小さなRNAシーケンシング
    • チップシーケンス
    • その他の遺伝子制御ベースのサービス
  • 動物と植物の配列解析
  • その他のシーケンスサービス

次世代シーケンシングサービス市場規模:技術別

  • 市場概要
  • 合成によるシーケンシング
  • イオン半導体シーケンシング
  • ナノポアシーケンシング
  • 単一分子リアルタイムシーケンシング
  • その他のテクノロジー

次世代シーケンシングサービス市場規模:ワークフロー別

  • 市場概要
  • 事前シーケンス
  • シーケンシング
  • データ分析

次世代シーケンシングサービス市場規模:最終用途別

  • 市場概要
  • 大学およびその他の調査機関
  • 病院・クリニック
  • 製薬およびバイオテクノロジー企業
  • その他

次世代シーケンシングサービス市場規模:用途別

  • 市場概要
  • 診断
  • 腫瘍学
  • 生殖に関する健康
  • 感染症
  • 稀な遺伝性疾患
  • その他
  • 創薬
  • バイオマーカーの発見
  • 微生物遺伝学農業動物調査
  • その他の用途

次世代シーケンシングサービス市場規模

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Illumina, Inc.(USA)
  • Thermo Fisher Scientific Inc.(USA)
  • BGI Genomics Co., Ltd.(China)
  • Eurofins Scientific SE(Luxembourg)
  • QIAGEN N.V.(Netherlands)
  • Agilent Technologies, Inc.(USA)
  • PerkinElmer, Inc.(USA)
  • Macrogen, Inc.(South Korea)
  • Pacific Biosciences of California, Inc.(USA)
  • Oxford Nanopore Technologies plc(UK)
  • Novogene Co., Ltd.(China)
  • Psomagen, Inc.(USA)
  • 10x Genomics, Inc.(USA)
  • Takara Bio Inc.(Japan)
  • Zymo Research Corp.(USA)
  • CD Genomics(USA)
  • MedGenome Labs Pvt Ltd.(India)
  • Fulgent Genetics, Inc.(USA)
  • Personalis, Inc.(USA)

結論と推奨事項

目次
Product Code: SQSG35A2092

Global Next-Generation Sequencing Services Market size was valued at USD 8.4 billion in 2023 and is poised to grow from USD 10.28 billion in 2024 to USD 51.80 billion by 2032, growing at a CAGR of 22.4% during the forecast period (2025-2032).

Next-generation sequencing (NGS), also known as massively parallel sequencing, revolutionizes fields such as biotechnology, medical diagnostics, and virology by enabling rapid and high-throughput DNA sequencing. This technology significantly reduces the time required to sequence a complete human genome compared to traditional Sanger methods, enhancing clinical and applied research. NGS facilitates crucial DNA pre-sequencing steps, enabling streamlined sample preparation and analysis. Its growing application in clinical laboratories allows for quicker illness diagnosis and more efficient drug discovery in pharmacogenomics. By identifying biomarkers for early detection and enabling personalized treatment strategies, NGS catalyzes the shift towards precision medicine, demonstrating its transformative impact on molecular biology and genetics despite being relatively new to the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Next-Generation Sequencing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Next-Generation Sequencing Services Market Segmental Analysis

Global Next-Generation Sequencing Services Market is segmented by type, technology, workflow, end use, application and region. Based on type, the market is segmented into human genome sequencing, single cell sequencing, microbial genome-based sequencing, gene regulation services, animal & plant sequencing and other sequencing services. Based on technology, the market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing and other technologies. Based on workflow, the market is segmented into pre-sequencing, sequencing and data analysis. Based on end use, the market is segmented into universities & other research entities, hospitals & clinics, pharma & biotech entities and others. Based on application, the market is segmented into diagnostics, oncology, reproductive health, infectious diseases, rare genetic disorders, others, drug discovery, biomarker discovery, microbial genetics, agriculture, and animal research and other applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Next-Generation Sequencing Services Market

The global Next-Generation Sequencing (NGS) services market is experiencing significant growth, primarily driven by advancements in clinical diagnostics across various fields, including forensics, reproductive health, and personalized medicine. NGS has emerged as the industry benchmark in clinical laboratories for diagnosing genetic disorders due to its analytical precision, high throughput capabilities, and cost-effectiveness. As the technology becomes more affordable, NGS is increasingly accessible, facilitating the diagnosis and treatment of rare diseases through genomic approaches. Additionally, the expansion of library preparation options and the growing pool of trained personnel are further propelling market growth, while ongoing improvements in sequencing technologies pave the way for novel therapies targeting Mendelian disorders and cancer.

Restraints in the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing (NGS) Services market faces several restraints, primarily stemming from legal and ethical challenges associated with DNA sequencing. These concerns encompass issues such as identifiability, the release of research findings, potential stereotyping, the adequacy of consent, stigma, inclusion, and unequal benefits among different groups. Such ethical considerations significantly hinder market growth. Additionally, the challenges of establishing in-house high-throughput devices and interpreting the complex data generated by NGS platforms are critical factors that are anticipated to further impede market expansion in the upcoming years, creating a cautious atmosphere among stakeholders in the industry.

Market Trends of the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing (NGS) Services market is witnessing a significant shift towards advanced technologies such as third-generation sequencing, which bypass traditional clonal amplification and polymerase chain reaction (PCR) methodologies. Innovations in single-molecule sequencing and real-time sequencing offer advantages, including longer read lengths and simplified preparatory processes, which reduce the risk of PCR-related errors. Platforms like Single-Molecule Real-Time (SMRT) sequencing and the FRET Sequencing platform are gaining traction due to their high accuracy and efficiency, propelling the market forward. The growing demand for precision medicine, genomics research, and personalized healthcare is further driving the adoption of these next-gen solutions, positioning NGS services as a pivotal market trend.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Next-Generation Sequencing Services Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Human Genome Sequencing
  • Single Cell Sequencing
  • Microbial Genome-Based Sequencing
  • Gene Regulation Services
    • Small RNA Sequencing
    • Chip Sequencing
    • Other Gene Regulation-Based Services
  • Animal & Plant Sequencing
  • Other Sequencing Services

Global Next-Generation Sequencing Services Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Sequencing By Synthesis
  • Ion Semiconductor Sequencing
  • Nanopore Sequencing
  • Single-Molecule Real-Time Sequencing
  • Other Technologies

Global Next-Generation Sequencing Services Market Size by Workflow & CAGR (2025-2032)

  • Market Overview
  • Pre-Sequencing
  • Sequencing
  • Data Analysis

Global Next-Generation Sequencing Services Market Size by End Use & CAGR (2025-2032)

  • Market Overview
  • Universities & Other Research Entities
  • Hospitals & Clinics
  • Pharma & Biotech Entities
  • Others

Global Next-Generation Sequencing Services Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Diagnostics
  • Oncology
  • Reproductive Health
  • Infectious Diseases
  • Rare Genetic Disorders
  • Others
  • Drug Discovery
  • Biomarker Discovery
  • Microbial Genetics, Agriculture, And Animal Research
  • Other Applications

Global Next-Generation Sequencing Services Market Size & CAGR (2025-2032)

  • North America (Type, Technology, Workflow, End Use, Application)
    • US
    • Canada
  • Europe (Type, Technology, Workflow, End Use, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Technology, Workflow, End Use, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Technology, Workflow, End Use, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Technology, Workflow, End Use, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Illumina, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI Genomics Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific SE (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QIAGEN N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Macrogen, Inc. (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacific Biosciences of California, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oxford Nanopore Technologies plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novogene Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Psomagen, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 10x Genomics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Bio Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zymo Research Corp. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CD Genomics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedGenome Labs Pvt Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fulgent Genetics, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Personalis, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations